RCS - Deepverge PLC - Skin Trust Club wins Best New Disrupter Brand

DeepvergeAnnouncement

01/06/2022 13:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220601:nRSA6028Na&default-theme=true

RNS Number : 6028N  Deepverge PLC  01 June 2022

 

 

 

1 June 2022

 

DeepVerge PLC

 

("DeepVerge" or "the Company")

 

Skin Trust Club wins Best New Disrupter Brand at the Pure Beauty Global Awards
2022

 

Brand recognition gaining traction

 

DeepVerge Shanghai office re-opens post COVID-19 lockdowns

 

DeepVerge (LSE:DVRG.L) consumer skin test subsidiary brand Skin Trust Club has
won the Best New Disrupter Brand award at the Pure Beauty Global Awards 2022.
Now in its fifth year, the Pure Beauty Global Awards attracted over 500
entries from more than 40 countries across the globe and were judged by a
panel of highly respected industry experts.

 

Skin Trust Club incorporates an artificial intelligence Skincare App and Home
Test Kit that provide simple, at-home skin microbiome testing for personalised
skincare and skin health tracking. The self-administered skin swab is a remote
trial and allows the participant to conduct each stage of the trial without
interaction. Skin Trust Club's test generates a report that consumers can use
to manage their custom skincare regime. Analysis of skin attributes provides
information to create hundreds of different product combinations to suit a
person's unique skin microbiome.

 

Gerard Brandon, CEO of DeepVerge, comments:

"We are delighted to receive this award in recognition of the incredible pace
at which Skin Trust Club has gained a strong global reputation of providing
personalised daily skincare routine guidance based on our scientific
heritage.  People now recognise the importance of skin and want to understand
how best to protect it. Through our app, members receive a report based on a
single swab to find out their unique skin biome, in real-time, and within
their environment, to empower and inform their choice of skincare routine.
Skin Trust Club is truly the holy grail of scientific based skin care.  This
award clearly shows the demand which we only expect to grow over the coming
year.

 

On another note, we are relieved that restrictions are easing in China and our
office in Shanghai is back open for business.  The team have continued their
incredible work throughout the pandemic, and I would like to thank them for
their commitment and dedication during these challenging times."

 

 

 

For further information please contact:

 

 DeepVerge plc                                   Gerard Brandon, CEO         +44 (0) 7340 055 648

 SPARK Advisory Partners Limited                 Neil Baldwin/Andrew Emmott  +44 (0) 113 370 8974

 (Nominated Adviser)

 Turner Pope Investments (TPI) Limited (Broker)  Andy Thacker/James Pope     +44 (0) 20 3657 0050

 

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that
develops and applies AI and IoT technology to analytical instruments for the
analysis and identification of bacteria, virus and toxins. Utilising
artificial intelligent data analytics to scientifically prove the impact of
skincare product claims on skin microbiome for most of the top 20 global
cosmetic company clients and remotely detect and identify in real-time,
dangerous pathogens in wastewater treatment plants, drinking water, rivers,
lakes and reservoirs.

 

Skin Trust Club

Skin Trust Club incorporates an artificial intelligence Skincare App and Home
Test Kit that provide simple, at-home skin microbiome testing for personalised
skincare and skin health tracking. The self-administered skin swab is a remote
trial and allows the participant to conduct each stage of the trial without
interaction. Skin Trust Club's DNA Test generates a report that consumers can
use to manage their custom skincare regime. Analysis of skin attributes
provides information to create hundreds of different product combinations to
suit a person's unique skin microbiome.

 

Labskin (Life Science Division)

Labskin is a 3D human skin equivalent test platform that scientifically proves
the impact of skincare product claims in healthcare, life sciences, skin
microbiome clinical trials, pharmaceutical and cosmetics industries. Labskin
have been pioneering the development of a laboratory grown human skin platform
for 15 years and is the only commercially available lab-grown full thickness
human skin model that naturally mimic the skins' microbiome. Labskin's virtual
clinical trials with remote collection of human volunteers' skin microbiome
provides a solution for the collection of volunteer microbiomes to allow for
lab-controlled trials of advanced skin models and human microbiomes. As the
data bank of remote volunteers grow, the higher the accuracy and increased
reliability of virtual product testing that can be provided to clients,
eliminating early human trial and error testing and resulting in a faster time
to market. The Labskin test platform and protocols help clients maintain an
optimum real-world environment, when testing their new ingredients and
existing products, that shows the positive or negative impact on skin's
natural microflora.

 

About Reach announcements

Reach is an investor communication service aimed at assisting listed and
unlisted (including AIM quoted) companies to distribute media only /
non-regulatory news releases such as marketing messages, corporate and product
information into the public domain. An RNS Regulatory announcement is required
to be notified under the AIM Rules for Companies.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAEAAKFEDLAEFA